Related Experiment Video
Updated: Jul 31, 2026

Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Rewards in practice from chrono-meta-analyses 'recycling' heart rate, ectopy, ischemia and blood pressure information
F Halberg1, G Cornélissen, K Otsuka
1Chronobiology Laboratories, University of Minnesota, Minneapolis, USA.
Insights
This study reveals that both atenolol and diltiazem reduce ischemia duration in coronary artery disease patients. Analyzing circadian and circaseptan rhythms helps optimize drug timing and monitor treatment effectiveness.
Area of Science:
- Cardiology
- Chronobiology
- Pharmacology
Background:
- Coronary artery disease (CAD) management involves monitoring heart rate and ischemia duration.
- Circadian (about-daily) and circaseptan (about-weekly) rhythms influence cardiovascular variables.
- Understanding treatment effects on these rhythms is crucial for optimizing patient care.
Purpose of the Study:
- To re-analyze existing data on heart rate and ischemia duration in CAD patients.
- To assess circadian and circaseptan changes in these variables under placebo, atenolol, and diltiazem treatment.
- To evaluate the impact of atenolol and diltiazem on cardiovascular rhythm characteristics.
Main Methods:
- Re-analysis of previously published average curves of heart rate and ischemia duration.
- Assessment of circadian and circaseptan patterns in cardiovascular variables.
- Comparison of rhythm characteristics between placebo and drug treatment (atenolol, diltiazem).
Main Results:
- A circaseptan pattern was observed for ischemia duration and heart rate.
- Both atenolol and diltiazem decreased ischemia duration.
- Atenolol, but not diltiazem, affected circadian amplitude and acrophase of ischemia duration.
- Both drugs lowered heart rate and its circadian amplitude and 24-h standard deviation, with atenolol showing a more pronounced effect.
Conclusions:
- Circadian and circaseptan rhythms and their modulation by atenolol and diltiazem are important in CAD.
- Timing of drug administration based on chronobiologic principles can optimize treatment.
- Chronobiologic surveillance via implantable devices can validate therapy and provide early warnings of disease risk.
Abstract:
Previously published average curves of heart rate and duration of ischemia in patients with coronary artery disease, studied while on placebo or on treatment with either atenolol or diltiazem, are re-analysed for the assessment of about-daily (circadian) and about-weekly (circaseptan) changes in these variables and of any treatment effect on rhythm characteristics. In addition to circadians, a circaseptan pattern characterizes the duration of ischemia in all three aforementioned study stages. Both drugs decrease the duration of ischemia, atenolol, but not diltiazem, also affects the circadian amplitude and acrophase of this variable. A circaseptan pattern is also found for heart rate on placebo and on treatment with atenolol, but not with diltiazem. Both drugs lower heart rate and the circadian amplitude and 24-h standard deviation of heart rate, atenolol much more markedly than diltiazem. Circadian and circaseptan rhythm characteristics and their alterations with treatment serve to optimize treatment by timing its administration. Chronobiologic surveillance of variables that are being readily monitored as-one-goes by modern implantable devices can also serve for the validation of the effectiveness of drug and electrical therapy. Rhythm alterations, in turn, can provide the earliest warnings of an elevated disease risk and lead to an improved diagnosis.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Measurement of Blood Pressure
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

